SK ChemicalsLtd Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de SK ChemicalsLtd.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	58.0%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Mar 22

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Mar 02

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

Feb 08

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Dec 30

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Dec 09

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Nov 19

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como SK ChemicalsLtd no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

KOSE:A285130 - Estimaciones futuras de los analistas y datos financieros pasados (KRW Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	1,765,283	15,929	-247,563	175,823	N/A
12/31/2023	1,748,778	35,689	-253,836	146,064	N/A
9/30/2023	1,794,436	126,293	-450,231	41,401	N/A
6/30/2023	1,645,542	114,243	-568,738	-109,260	N/A
3/31/2023	1,775,509	170,141	-490,438	-72,730	N/A
12/31/2022	1,829,191	191,266	-487,999	-186,536	N/A
9/30/2022	2,123,241	214,870	-116,892	122,870	N/A
6/30/2022	2,209,667	237,197	-57,927	145,968	N/A
3/31/2022	2,134,811	249,610	4,324	170,726	N/A
12/31/2021	2,089,632	270,006	362,192	509,316	N/A
9/30/2021	1,624,068	219,644	168,295	301,840	N/A
6/30/2021	1,457,229	197,761	196,194	302,769	N/A
3/31/2021	1,319,192	139,871	320,393	416,907	N/A
12/31/2020	1,198,781	89,080	153,469	247,010	N/A
9/30/2020	1,173,655	38,647	88,992	179,371	N/A
6/30/2020	1,105,648	-5,652	60,643	162,730	N/A
3/31/2020	1,112,535	615	-20,140	99,927	N/A
12/31/2019	1,112,919	-17,420	-5,520	122,135	N/A
9/30/2019	1,155,857	-43,090	-25,916	95,654	N/A
6/30/2019	1,248,197	-15,342	-6,781	106,471	N/A
3/31/2019	1,306,638	-11,800	-3,695	86,041	N/A
12/31/2018	1,367,719	6,028	-16,905	67,370	N/A
12/31/2017	1,054,037	-102,431	N/A	-128,022	N/A
12/31/2016	1,146,626	11,687	N/A	N/A	N/A
12/31/2015	1,039,864	119,950	N/A	N/A	N/A
12/31/2014	1,232,854	-20,128	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de A285130 es superior a la tasa de ahorro (2.4%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de A285130 crezcan más rápidamente que el mercado KR

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de A285130 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de A285130 crezcan más rápidamente que el mercado de KR.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de A285130 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de A285130 se prevé que sea elevada dentro de 3 años.

SK ChemicalsLtd Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased to ₩130,000

Price target increased to ₩333,333

Price target increased to ₩333,333

Price target raised to ₩513,333

Analysts increase EPS estimates to ₩17,352

Analysts update estimates

Recent updates

First quarter 2024 earnings released: ₩214 loss per share (vs ₩816 profit in 1Q 2023)

SK chemicals Unveils Blueprint for Circular Recycle™ and Solutions

SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩2,072 (vs ₩9,910 in FY 2022)

There Is A Reason SK Chemicals Co.,Ltd's (KRX:285130) Price Is Undemanding

Upcoming dividend of ₩1,100 per share at 2.2% yield

Third quarter 2023 earnings released: EPS: ₩2,441 (vs ₩1,815 in 3Q 2022)

Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130).

New minor risk - Profit margin trend

Upcoming dividend of ₩400 per share at 1.5% yield

First quarter 2023 earnings released: EPS: ₩816 (vs ₩1,881 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to ₩130,000

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Price target increased to ₩333,333

Price target increased to ₩333,333

Upcoming dividend of ₩1,333 per share

Metrica Partners Calls for a Strategic Review at SK Chemicals

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Metrica Partners Sends Letter to SK Chemicals

We Think SK ChemicalsLtd's (KRX:285130) Robust Earnings Are Conservative

Full year 2020 earnings released: EPS ₩621 (vs ₩1,318 loss in FY 2019)

Should You Think About Buying SK Chemicals Co.,Ltd. (KRX:285130) Now?

Investor sentiment deteriorated over the past week

SK Chemicals Co.,Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day low: ₩347,000

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Daejung Chemicals & Metals Co.,Ltd. (KOSDAQ:A120240) acquired 50% in Sk Chemicals Daejung Co,. Ltd from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 6 billion.

Price target raised to ₩513,333

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

New 90-day high: ₩462,500

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Standigm Inc. and K Chemicals Co., Ltd. Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Upcoming Dividend of ₩450 Per Share

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Analysts increase EPS estimates to ₩17,352

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Analysts update estimates

New 90-day high: ₩449,500

Kyung-joo Park and other investors acquired 16.03% stake in JSI Co. Ltd. from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 0.04 million.

New 90-day high - ₩314,000

Price target raised to ₩183,750

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento